BACKGROUND: Left ventricular dilatation and elevated plasma natriuretic peptide levels
predict adverse prognosis and the development of congestive heart failure after myocardial …

Aims Matrix metalloproteinase (MMP) activity is central to the development of left ventricular
(LV) remodelling and dysfunction after acute myocardial infarction (AMI). We assessed the …

BACKGROUND: Altered activity of the matrix metalloproteinases (MMP-2 and-9), has been
implicated in the left ventricular (LV) remodeling process occurring after myocardial …

BACKGROUND: Matrix metalloproteinases (MMPs) have been associated with the
development of left ventricular remodeling after myocardial infarction (MI). We sought to …

Objective Left ventricular (LV) remodeling following myocardial infarction (MI) is
characterized by progressive alterations of structure and function, named LV remodeling …

Aim To describe temporal profiles of plasma matrix metalloproteinases (MMP-2 and MMP-9),
and their relationship with echocardiographic (Echo) parameters of left ventricular (LV) …

OBJECTIVE: To test the hypothesis that changes in serum matrix metalloproteinase-1 (MMP-
1) and tissue inhibitors of metalloproteinase-1 (TIMP-1) after acute myocardial infarction …

Background—Changes in matrix metalloproteinase (MMP) and tissue inhibitors of MMPs
(TIMPs) contribute to left ventricular (LV) remodeling after myocardial infarction (MI). We …

Abstract Matrix metalloproteinase (MMP)-2 and MMP-9 are believed to play a
pathophysiologic role in acute myocardial infarction (MI). The time course of their plasma …

The left ventricular ejection fraction (LVEF) is one of the major prognostic factors after acute
myocardial infarction (AMI) and matrix metalloproteinase-1 (MMP-1) is an enzyme …